<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS189612</article-id><article-id pub-id-type="doi">10.1101/2023.10.11.561544</article-id><article-id pub-id-type="archive">PPR740205</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Sarbecovirus disease susceptibility is conserved across viral and host models</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leist</surname><given-names>Sarah R.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sch√§fer</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Risemberg</surname><given-names>Ellen L</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Bell</surname><given-names>Timothy A.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hock</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zweigart</surname><given-names>Mark R.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Linnertz</surname><given-names>Colton L.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Darla R.</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Ginger D.</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>de Villena</surname><given-names>Fernando Pardo Manuel</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ferris</surname><given-names>Martin T.</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="fn" rid="FN2">$</xref></contrib><contrib contrib-type="author"><name><surname>Valdar</surname><given-names>William</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="fn" rid="FN2">$</xref></contrib><contrib contrib-type="author"><name><surname>Baric</surname><given-names>Ralph S.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="fn" rid="FN2">$</xref></contrib><aff id="A1"><label>1</label>Department of Epidemiology, University of North Carolina at Chapel Hill</aff><aff id="A2"><label>2</label>Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill</aff><aff id="A3"><label>3</label>Department of Genetics, University of North Carolina at Chapel Hill</aff><aff id="A4"><label>4</label>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill</aff><aff id="A5"><label>5</label>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</aff></contrib-group><author-notes><fn id="FN1" fn-type="equal"><label>*</label><p id="P1">Authors contributed equally to work</p></fn><fn id="FN2" fn-type="equal"><label>$</label><p id="P2">Authors contributed equally to work</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>15</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>12</day><month>10</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P3">Coronaviruses have caused three severe epidemics since the start of the 21<sup>st</sup> century: SARS, MERS and COVID-19. The severity of the ongoing COVID-19 pandemic and increasing likelihood of future coronavirus outbreaks motivates greater understanding of factors leading to severe coronavirus disease. We screened ten strains from the Collaborative Cross mouse genetic reference panel and identified strains CC006/TauUnc (CC006) and CC044/Unc (CC044) as coronavirus-susceptible and resistant, respectively, as indicated by variable weight loss and lung congestion scores four days post-infection. We generated a genetic mapping population of 755 CC006xCC044 F2 mice and exposed the mice to one of three genetically distinct mouse-adapted coronaviruses: clade 1a SARS-CoV MA15 (n=391), clade 1b SARS-CoV-2 MA10 (n=274), and clade 2 HKU3-CoV MA (n=90). Quantitative trait loci (QTL) mapping in SARS-CoV- and SARS-CoV-2-infected F2 mice identified genetic loci associated with disease severity. Specifically, we identified seven loci associated with variation in outcome following infection with either virus, including one, <italic>HrS45</italic>, that is present in both groups. Three of these QTL, including <italic>HrS45</italic>, were also associated with HKU3-CoV MA outcome. <italic>HrS45</italic> overlaps with a QTL previously reported by our lab that is associated with SARS-CoV outcome in CC011xCC074 F2 mice and is also syntenic with a human chromosomal region associated with severe COVID-19 outcomes in humans GWAS. The results reported here provide: (a) additional support for the involvement of this locus in SARS-CoV MA15 infection, (b) the first conclusive evidence that this locus is associated with susceptibility across the <italic>Sarbecovirus</italic> subgenus, and (c) demonstration of the relevance of mouse models in the study of coronavirus disease susceptibility in humans.</p></abstract></article-meta></front><body><p id="P4">Over the last three decades, three zoonotic coronaviruses have emerged in humans: SARS-CoV in 2003 (<xref ref-type="bibr" rid="R33">Zhong et al., 2003</xref>), MERS-CoV in 2012 (<xref ref-type="bibr" rid="R13">Hijawi et al., 2013</xref>) and SARS-CoV-2 in late 2019 (<xref ref-type="bibr" rid="R34">Zhou et al., 2020a</xref>, <xref ref-type="bibr" rid="R35">Zhou et al., 2020b</xref>). SARS-CoV-2 is the causative agent of the ongoing COVID-19 pandemic. Despite the public health emergency being declared over as of May 11<sup>th</sup>, 2023 (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/your-health/end-of-phe.html">https://www.cdc.gov/coronavirus/2019-ncov/your-health/end-of-phe.html</ext-link>), acute infections with constantly evolving Variants of Concern (VoCs) as well as post-acute sequelae weeks to months after infection pose ongoing global health burdens. Furthermore, it has been shown that coronaviruses in natural animal reservoirs like bats are poised for human emergence (<xref ref-type="bibr" rid="R17">Menachery et al., 2015</xref>) and that climate change increases the likelihood of future transmission of viruses from animal to humans (<xref ref-type="bibr" rid="R5">Carlson et al., 2022</xref>). Despite a surge in worldwide efforts in understanding disease mechanisms for countermeasure development, many aspects of the disease caused by SARS-CoV-2 specifically, but also sarbecoviruses and other coronaviruses in general, remain elusive. Thus, the need to understand mechanisms driving disease progression, outcome, and ways to intervene remains of high priority.</p><p id="P5">Murine model systems are one of the most widely used biomedical research tools with which to investigate infectious disease mechanisms and pathogenesis <italic>in vivo</italic>. Mouse-adapted versions of both viruses (SARS-CoV MA15 (<xref ref-type="bibr" rid="R21">Roberts et al., 2007</xref>) and SARS-CoV-2 MA10 (<xref ref-type="bibr" rid="R15">Leist et al., 2020</xref>) have been used in multiple studies showing their potential to replicate acute respiratory distress syndrome (ARDS) as seen in the human population (<xref ref-type="bibr" rid="R31">Yan et al., 2022</xref>, <xref ref-type="bibr" rid="R27">Thieulent et al., 2023</xref>, <xref ref-type="bibr" rid="R15">Leist et al., 2020</xref>). Even with these available tools, most of these studies focus on one or a few classical mouse strains (e.g. BALB/c or C57BL/6 (<xref ref-type="bibr" rid="R10">Gralinski et al., 2013</xref>, <xref ref-type="bibr" rid="R1">Adams et al., 2023</xref>)), which neglects the effect of host genetic background on driving disease outcomes. Genetically diverse mouse genetic reference panels allow us to examine host genetic factors contributing to viral disease severity and outcomes.</p><p id="P6">Host susceptibility loci that regulate coronavirus infection response were first reported with mouse hepatitis virus (MHV) in mice (<xref ref-type="bibr" rid="R19">Ohtsuka and Taguchi, 1997</xref>). Over the past decade, we have utilized the Collaborative Cross (CC) genetic reference panel to study a variety of viral pathogens, including the identification of several genetic loci associated with SARS-CoV infectious outcomes (<xref ref-type="bibr" rid="R9">Ferris et al., 2013</xref>, <xref ref-type="bibr" rid="R18">Noll et al., 2020</xref>, <xref ref-type="bibr" rid="R11">Gralinski et al., 2015</xref>, <xref ref-type="bibr" rid="R16">Maurizio et al., 2018</xref>, <xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>). The CC is a large panel of recombinant inbred (RI) strains derived from eight genetically diverse founder strains and designed specifically for complex trait analysis and systems genetics approaches (initially described in (<xref ref-type="bibr" rid="R28">Threadgill et al., 2011</xref>) and reviewed more fully in (<xref ref-type="bibr" rid="R14">Leist and Baric, 2018</xref>)). Herein, we use an F2 cross between coronavirus-susceptible CC006/TauUnc and coronavirus-resistant CC044/Unc (hereafter, CC006 and CC044, respectively) mice to more thoroughly investigate the genetic architecture underlying both SARS-CoV and SARS-CoV-2 disease outcomes, as well as assess concordance with a pre-emergent (HKU3-CoV) virus.</p><p id="P7">We purchased a set of 10 CC strains (listed in <xref ref-type="fig" rid="F1">Fig 1.A-C</xref>) from the System‚Äôs Genetics Core Facility (SGCF) at UNC, and screened them for divergent responses to SARS-CoV MA15 infection. Four 10-week-old female mice from each of these ten CC strains were intra-nasally infected with 10<sup>4</sup> plaque-forming units (PFU) of mouse-adapted SARS-CoV MA15 (<xref ref-type="bibr" rid="R21">Roberts et al., 2007</xref>), and changes in body weight were monitored for four days post-infection (dpi). Lung congestion scores as a gross evaluation of histopathological changes at the time point of harvest as well as viral titer in lungs on day 4 were measured. Viral titers were determined by plaque assay, as previously described (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>). We observed highly variant disease outcomes in terms of weight loss (<bold><xref ref-type="fig" rid="F1">Fig. 1A</xref></bold>), congestion scores (<bold><xref ref-type="fig" rid="F1">Fig. 1B</xref></bold>) and viral titer (<bold><xref ref-type="fig" rid="F1">Fig. 1C</xref></bold>) across these ten strains. From this screen we identified CC006 as susceptible and CC044 as resistant to severe disease. CC006 exhibited a severe disease response marked by 50% mortality and 19% loss of body weight on average in surviving mice by day 4 post-infection. In contrast, CC044 mice were resistant to disease, with no mortality and little if any change in body weight on average. The overall weight loss trajectories (area above the curve, AAC) of CC006 and CC044 mice were significantly different from each other (p = 6x10<sup>-3</sup>, Tukey‚Äôs HSD). CC006 mice also exhibited significantly higher congestion scores than CC044 mice (p = 1x10<sup>-4</sup>, Tukey‚Äôs HSD test). Importantly, while these strains had divergent disease responses, they showed similar viral loads (p = 0.99, Tukey‚Äôs HSD test), suggesting that variation in disease severity is due to variable host response rather than variation in viral burden. Following the initial screen, we repeated this experiment with CC006, CC044, and CC023/GeniUnc and validated their divergent responses (<bold><xref ref-type="fig" rid="F1">Fig. 1D-F</xref></bold>). Weight loss trajectories (<bold><xref ref-type="fig" rid="F1">Fig. 1D</xref></bold>, p = 3x10<sup>-4</sup>) but not congestion scores (<bold><xref ref-type="fig" rid="F1">Fig. 1E</xref></bold>, p = 0.13) were significantly different from each other between CC006 and CC044 in this repeat experiment. As in the original screen, titer was not significantly different between CC006 and CC044 mice (<bold><xref ref-type="fig" rid="F1">Fig. 1F</xref></bold>, p = 0.53). As such, CC006 and CC044 seemed strong candidates to generate a targeted F2 cross for genetic mapping.</p><p id="P8">We generated a genetic mapping population of CC006xCC044 F2 mice, using a balanced breeding design as we have previously described (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>, <xref ref-type="bibr" rid="R12">Gralinski et al., 2017</xref>). In total, we generated 755 F2 mice from all four grandparental combinations. These F2 mice were exposed to one of three coronaviruses: the clade Ia sarbecovirus SARS-CoV MA15 (n=391), the clade Ib sarbecovirus SARS-CoV-2 MA10 (n=274) and also the clade II sarbecovirus HKU3-CoV (HKU3-CoV MA) (n=90), a mouse-adapted bat virus (<xref ref-type="bibr" rid="R3">Becker et al., 2008</xref>). We assessed disease severity and progression by measuring weight loss for four days following infection, and at 4 dpi, we euthanized the mice and assessed their overall lung pathology in the form of a congestion score. Weight loss following SARS-CoV MA15 (<bold><xref ref-type="fig" rid="F2">Fig. 2A</xref></bold>) and SARS-CoV-2 MA10 (<bold><xref ref-type="fig" rid="F2">Fig. 2B</xref></bold>) infection in these F2 mice expanded the range of what was observed in the parental strains following SARS-CoV MA15 infection (<bold><xref ref-type="fig" rid="F1">Fig. 1A</xref></bold>), as is often observed in our mapping crosses (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>, <xref ref-type="bibr" rid="R26">Smith et al., 2016</xref>, <xref ref-type="bibr" rid="R12">Gralinski et al., 2017</xref>) (). F2 mice infected with SARS-CoV MA15 lost an average of 5% (ranging from a 7% gain to 26% loss) of their body weight, with congestion scores between 0-4 (median = 0.5). F2 mice infected with SARS-CoV-2 MA10 lost an average of 6% (ranging from 33% gain to 28% loss) of their body weight, with congestion scores between 0-4 (median = 0.5). F2 mice infected with HKU3-CoV MA exhibited less severe weight loss and congestion scores compared to those infected with SARS-CoV MA15 and SARS-CoV-2 MA10. There was still a substantial range of disease responses after HKU3-CoV MA infection, with mice losing an average of 1% (ranging from 7% gain to 13% loss) of their body weight by day 4 and congestion scores ranging from 0-2 (median = 0.5). These results highlight the value of our mouse-adapted viruses, SARS-CoV MA15 and SARS-CoV-2 MA10, in leading to highly correlated parameters of disease manifestation. The evaluation of coronavirus-induced disease across three different viruses indicates that there might be host genetic mechanisms that lead to common disease responses despite genetic differences across coronaviruses, and thus increases the impact of the findings to potentially encompass future viral epidemics.</p><p id="P9">Concurrent with viral challenge, we genotyped these F2 mice on the miniMUGA array (<xref ref-type="bibr" rid="R25">Sigmon et al., 2020</xref>). We filtered the 10,819 biallelic single nucleotide polymorphisms (SNPs) down to a set of 2,599 well-performing markers which segregated between CC006 and CC044 on the autosomes and X-chromosome. These markers were well-distributed across the genome, with a median and maximum distance between markers of 0.5 Mb and 50 Mb, respectively. Using this set of markers, we performed QTL mapping using R/qtl (<xref ref-type="bibr" rid="R4">Broman et al., 2003</xref>) in both the SARS-CoV MA15- and SARS-CoV-2 MA10-infected mice. For each virus, mapping was performed on five phenotypes: weight on each of days 2-4 (with weight on day 0 as a covariate to control for baseline weight), an ‚Äúarea above the curve‚Äù (AAC) measure to capture the overall weight loss trajectory for each mouse, and congestion score. We identified a total of seven loci associated with these aspects of coronavirus disease severity (<xref ref-type="table" rid="T1">Table 1</xref>), six significant loci (<italic>HrS43-48</italic>, P &lt; 0.05) and 1 suggestive locus (<italic>HrS49</italic>, P &lt; 0.10).</p><p id="P10"><italic>HrS43</italic> overlaps with a locus we had previously identified, <italic>HrS26</italic>, that was associated with multiple disease traits following SARS-CoV MA15 infection in a CC011xCC074 F2 cross (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>). As with <italic>HrS26, HrS43</italic> is associated with both weight loss and congestion scores following SARS-CoV MA15 infection (<bold><xref ref-type="fig" rid="F3">Fig. 3A-B</xref>, <xref ref-type="fig" rid="F4">Fig. 4A</xref></bold>). We also show that <italic>HrS43</italic> is associated with weight loss and congestion scores following SARS-CoV-2 MA10 (<bold><xref ref-type="fig" rid="F3">Fig. 3C-D</xref>, <xref ref-type="fig" rid="F4">Fig. 4B</xref></bold>) infection. Mapping this locus in two independent studies strengthens support for this locus as a driver of disease. Although we lacked sufficient sample size for QTL mapping in the HKU3-CoV-MA-infected mice, we asked whether there was evidence that <italic>HrS43</italic> also impacts HKU3-CoV MA infection outcome. <italic>HrS43</italic> was associated with both weight loss on day 2 (P=0.01) and weight AAC (P=0.05, <bold><xref ref-type="fig" rid="F4">Fig. 4C</xref></bold>). Other QTL associated with disease outcomes following HKU3-CoV MA infection were <italic>HrS44</italic> (weight loss on day 3 (p=0.02), day 4 (p=0.05), and AAC (p=0.02)) and <italic>HrS46</italic> (congestion score (p=0.03)).</p><p id="P11">Consistent with other studies (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>, <xref ref-type="bibr" rid="R12">Gralinski et al., 2017</xref>, <xref ref-type="bibr" rid="R11">Gralinski et al., 2015</xref>), we have shown that response to sarbecovirus infection within this cross is influenced by multiple loci. Importantly, our results here provide evidence, first suggested in our prior study (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>), that <italic>HrS26</italic>/<italic>HrS43</italic> affect susceptibility via a pan-coronavirus mechanism. Importantly, this locus also appears to be evolutionarily conserved across mammals, as the syntenic region in humans was associated with severe COVID-19 disease in several GWAS (<xref ref-type="bibr" rid="R8">Covid-19 Host Genetics Initiative, 2021</xref>, <xref ref-type="bibr" rid="R23">Severe Covid-19 GWAS Group, 2020</xref>, <xref ref-type="bibr" rid="R20">Pairo-Castineira et al., 2021</xref>, <xref ref-type="bibr" rid="R24">Shelton et al., 2021</xref>). Given the overlap between <italic>HrS26</italic> and <italic>HrS43</italic>, and the apparent cross-species and cross-coronavirus relevance, we sought to use genetic data from both crosses to improve our assessment of candidate genes. In our previous study (<xref ref-type="bibr" rid="R22">Schafer et al., 2022</xref>), we reported genes that had variants segregating between the strains involved in that study, CC011 and CC074. Here, since the founder strain haplotypes segregating between CC011 and CC074 are different than those between CC006 and CC044, we can provide further refinement by looking for candidate genes with variants segregating between the strains in both crosses. We categorize candidate genes as those with shared SNPs that indicated a common variant affecting susceptibility and those with SNPs that are not shared but point to common susceptibility genes. This approach allowed us to refine potential candidate genes from 971 within the locus to 304. We also report genes that are indicated in one cross but not the other (i.e. variants suggesting genetic pleiotropy).</p><p id="P12">Using this refined analysis, we cross-indexed our results with several genes that have been associated with severe COVID-19 in human GWAS (<xref ref-type="bibr" rid="R7">Coperchini et al., 2020</xref>). These studies have pointed to a cluster of six genes located on human chromosome 3 (syntenic with distal mouse chromosome 9, where <italic>HrS26</italic> and <italic>HrS43</italic> localize): <italic>SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6</italic>, and <italic>XCR1</italic>. In our earlier study, we demonstrated that at least two of the genes underneath this locus (<italic>Cxcr6</italic> and <italic>Ccr9</italic>) contributed to these disease responses. Besides the six genes associated with severe COVID-19, we identified variants of several other genes within <italic>HrS43</italic> with involvement in immunological and antiviral processes and which have been shown to specifically have a role during COVID-19 development and disease. Several chemokine receptors, like <italic>Ccr4, Ccr8, and Cx3cr1</italic>, are involved in shaping the specific immune (adaptive) responses during SARS-CoV-2 infection (<xref ref-type="bibr" rid="R30">Wang et al., 2022</xref>, <xref ref-type="bibr" rid="R32">Zhang et al., 2022</xref>, <xref ref-type="bibr" rid="R36">Zhou et al., 2021</xref>, <xref ref-type="bibr" rid="R29">Victor et al., 2022</xref>), while allelic variants (<italic>Cmtm8, Cspg5, Dbr1, Gnai2</italic>, and <italic>Mlh1</italic>) have been described to have functions in DNA splicing, stability, and maintenance during COVID-19 disease (<xref ref-type="bibr" rid="R6">Chen et al., 2021</xref>, <xref ref-type="bibr" rid="R2">Ariumi, 2022</xref>). Interestingly, we also identified two genes, <italic>Dcaf1</italic>, a regulator of TMPRSS2 expression, and <italic>Xrn1</italic>, an exonuclease, two cellular genes, which are directly involved in the SARS-CoV-2 replication (<xref ref-type="bibr" rid="R6">Chen et al., 2021</xref>, <xref ref-type="bibr" rid="R2">Ariumi, 2022</xref>).</p><p id="P13">Here, we show that several disease phenotypes during SARS-CoV MA15, SARS-CoV-2 MA10 and HKU3-CoV MA infection in a CC006xCC044 F2 cross are associated with a locus (<italic>HrS43</italic>) which is also associated with SARS-CoV-2 disease outcome in humans. As such, this study is the first to conclusively demonstrate that sarbecovirus disease is, in part, controlled by common host loci, and that this control is relevant across mammalian hosts. Such conserved and broadly relevant loci are of high interest for global public health outcomes, as they point to mechanisms of susceptibility that can inform treatment and intervention strategies for current and future viral epidemics. Further, consistent associations across mouse and human studies demonstrate that susceptibility mechanisms are conserved across mammals and supports the use of mouse models in the study of host genetic response to viral infection. Altogether, our studies point to a set of host genes driving these outcomes across both human and mouse systems, suggest that future virus emergences can be putatively treated based on prior emergence analyses, and reinforce the utility of mammalian model systems to inform our understanding of emerging infections.</p></body><back><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>LE</given-names></name><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Dinnon</surname><given-names>KH</given-names><suffix>3rd</suffix></name><name><surname>West</surname><given-names>RD</given-names></name><name><surname>Gully</surname><given-names>KL</given-names></name><name><surname>Anderson</surname><given-names>EJ</given-names></name><name><surname>Loome</surname><given-names>JF</given-names></name><name><surname>Madden</surname><given-names>EA</given-names></name><name><surname>Powers</surname><given-names>JM</given-names></name><name><surname>Schafer</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><elocation-id>112326</elocation-id><pub-id pub-id-type="pmcid">PMC10063157</pub-id><pub-id pub-id-type="pmid">37000623</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112326</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariumi</surname><given-names>Y</given-names></name></person-group><article-title>Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection</article-title><source>J Virol</source><year>2022</year><volume>96</volume><elocation-id>e0000222</elocation-id><pub-id pub-id-type="pmcid">PMC8941876</pub-id><pub-id pub-id-type="pmid">35107372</pub-id><pub-id pub-id-type="doi">10.1128/jvi.00002-22</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>MM</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Donaldson</surname><given-names>EF</given-names></name><name><surname>Rockx</surname><given-names>B</given-names></name><name><surname>Sims</surname><given-names>AC</given-names></name><name><surname>Sheahan</surname><given-names>T</given-names></name><name><surname>Pickles</surname><given-names>RJ</given-names></name><name><surname>Corti</surname><given-names>D</given-names></name><name><surname>Johnston</surname><given-names>RE</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name><name><surname>Denison</surname><given-names>MR</given-names></name></person-group><article-title>Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>19944</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC2588415</pub-id><pub-id pub-id-type="pmid">19036930</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0808116105</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Sen</surname><given-names>S</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name></person-group><article-title>R/qtl: QTL mapping in experimental crosses</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>889</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12724300</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>CJ</given-names></name><name><surname>Albery</surname><given-names>GF</given-names></name><name><surname>Merow</surname><given-names>C</given-names></name><name><surname>Trisos</surname><given-names>CH</given-names></name><name><surname>Zipfel</surname><given-names>CM</given-names></name><name><surname>Eskew</surname><given-names>EA</given-names></name><name><surname>Olival</surname><given-names>KJ</given-names></name><name><surname>Ross</surname><given-names>N</given-names></name><name><surname>Bansal</surname><given-names>S</given-names></name></person-group><article-title>Climate change increases cross-species viral transmission risk</article-title><source>Nature</source><year>2022</year><volume>607</volume><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">35483403</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lear</surname><given-names>TB</given-names></name><name><surname>Evankovich</surname><given-names>JW</given-names></name><name><surname>Larsen</surname><given-names>MB</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Alfaras</surname><given-names>I</given-names></name><name><surname>Kennerdell</surname><given-names>JR</given-names></name><name><surname>Salminen</surname><given-names>L</given-names></name><name><surname>Camarco</surname><given-names>DP</given-names></name><name><surname>Lockwood</surname><given-names>KC</given-names></name><name><surname>Tuncer</surname><given-names>F</given-names></name><etal/></person-group><article-title>A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>3907</elocation-id><pub-id pub-id-type="pmcid">PMC8222394</pub-id><pub-id pub-id-type="pmid">34162861</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-24156-y</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coperchini</surname><given-names>F</given-names></name><name><surname>Chiovato</surname><given-names>L</given-names></name><name><surname>Croce</surname><given-names>L</given-names></name><name><surname>Magri</surname><given-names>F</given-names></name><name><surname>Rotondi</surname><given-names>M</given-names></name></person-group><article-title>The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system</article-title><source>Cytokine Growth Factor Rev</source><year>2020</year><volume>53</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmcid">PMC7211650</pub-id><pub-id pub-id-type="pmid">32446778</pub-id><pub-id pub-id-type="doi">10.1016/j.cytogfr.2020.05.003</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><collab>Covid-19 Host Genetics Initiative</collab><article-title>Mapping the human genetic architecture of COVID-19</article-title><source>Nature</source><year>2021</year><volume>600</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="pmcid">PMC8674144</pub-id><pub-id pub-id-type="pmid">34237774</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-03767-x</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Aylor</surname><given-names>DL</given-names></name><name><surname>Bottomly</surname><given-names>D</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>Aicher</surname><given-names>LD</given-names></name><name><surname>Bell</surname><given-names>TA</given-names></name><name><surname>Bradel-Tretheway</surname><given-names>B</given-names></name><name><surname>Bryan</surname><given-names>JT</given-names></name><name><surname>Buus</surname><given-names>RJ</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Haagmans</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Modeling host genetic regulation of influenza pathogenesis in the collaborative cross</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003196</elocation-id><pub-id pub-id-type="pmcid">PMC3585141</pub-id><pub-id pub-id-type="pmid">23468633</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003196</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Bankhead</surname><given-names>A</given-names></name><name><surname>Jeng</surname><given-names>RD</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Proll</surname><given-names>S</given-names></name><name><surname>Belisle</surname><given-names>SE</given-names></name><name><surname>Matzke</surname><given-names>M</given-names></name><name><surname>Webb-Robertson</surname><given-names>BJ</given-names></name><name><surname>Luna</surname><given-names>ML</given-names></name><name><surname>Shukla</surname><given-names>AK</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury</article-title><source>mBio</source><year>2013</year><volume>4</volume><pub-id pub-id-type="pmcid">PMC3747576</pub-id><pub-id pub-id-type="pmid">23919993</pub-id><pub-id pub-id-type="doi">10.1128/mBio.00271-13</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Aylor</surname><given-names>DL</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Frieman</surname><given-names>MB</given-names></name><name><surname>Deming</surname><given-names>D</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Buus</surname><given-names>RJ</given-names></name><name><surname>Bell</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross</article-title><source>PLoS Genet</source><year>2015</year><volume>11</volume><elocation-id>e1005504</elocation-id><pub-id pub-id-type="pmcid">PMC4599853</pub-id><pub-id pub-id-type="pmid">26452100</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005504</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Morgan</surname><given-names>AP</given-names></name><name><surname>Totura</surname><given-names>AL</given-names></name><name><surname>Beall</surname><given-names>A</given-names></name><name><surname>Kocher</surname><given-names>J</given-names></name><name><surname>Plante</surname><given-names>J</given-names></name><name><surname>Harrison-Shostak</surname><given-names>DC</given-names></name><name><surname>Schafer</surname><given-names>A</given-names></name><name><surname>Pardo-Manuel De Villena</surname><given-names>F</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice</article-title><source>G3 (Bethesda)</source><year>2017</year><volume>7</volume><fpage>1653</fpage><lpage>1663</lpage><pub-id pub-id-type="pmcid">PMC5473747</pub-id><pub-id pub-id-type="pmid">28592648</pub-id><pub-id pub-id-type="doi">10.1534/g3.117.041434</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hijawi</surname><given-names>B</given-names></name><name><surname>Abdallat</surname><given-names>M</given-names></name><name><surname>Sayaydeh</surname><given-names>A</given-names></name><name><surname>Alqasrawi</surname><given-names>S</given-names></name><name><surname>Haddadin</surname><given-names>A</given-names></name><name><surname>Jaarour</surname><given-names>N</given-names></name><name><surname>Alsheikh</surname><given-names>S</given-names></name><name><surname>Alsanouri</surname><given-names>T</given-names></name></person-group><article-title>Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation</article-title><source>East Mediterr Health J</source><year>2013</year><volume>19</volume><supplement>Suppl 1</supplement><fpage>S12</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23888790</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name></person-group><article-title>Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections</article-title><source>Trends Genet</source><year>2018</year><volume>34</volume><fpage>777</fpage><lpage>789</lpage><pub-id pub-id-type="pmcid">PMC7114642</pub-id><pub-id pub-id-type="pmid">30131185</pub-id><pub-id pub-id-type="doi">10.1016/j.tig.2018.07.005</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Dinnon</surname><given-names>KH</given-names></name><name><surname>Schafer</surname><given-names>RD</given-names></name><name><surname>Tse</surname><given-names>LV</given-names></name><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Hou</surname><given-names>YJ</given-names></name><name><surname>West</surname><given-names>A</given-names></name><name><surname>Edwards</surname><given-names>CE</given-names></name><name><surname>Sanders</surname><given-names>W</given-names></name><name><surname>Fritch</surname><given-names>EJ</given-names></name><name><surname>Gully</surname><given-names>KL</given-names></name><etal/></person-group><article-title>A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice</article-title><source>Cell</source><year>2020</year><volume>183</volume><fpage>1070</fpage><lpage>1085</lpage><elocation-id>e12</elocation-id><pub-id pub-id-type="pmcid">PMC7510428</pub-id><pub-id pub-id-type="pmid">33031744</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.050</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurizio</surname><given-names>PL</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Keele</surname><given-names>GR</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Shaw</surname><given-names>GD</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>West</surname><given-names>A</given-names></name><name><surname>Morrison</surname><given-names>CR</given-names></name><name><surname>Noll</surname><given-names>KE</given-names></name><name><surname>Plante</surname><given-names>KS</given-names></name><name><surname>Cockrell</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Bayesian Diallel Analysis Reveals Mx1-Dependent and Mx1-Independent Effects on Response to Influenza A Virus in Mice</article-title><source>G3 (Bethesda)</source><year>2018</year><volume>8</volume><fpage>427</fpage><lpage>445</lpage><pub-id pub-id-type="pmcid">PMC5919740</pub-id><pub-id pub-id-type="pmid">29187420</pub-id><pub-id pub-id-type="doi">10.1534/g3.117.300438</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menachery</surname><given-names>VD</given-names></name><name><surname>Yount</surname><given-names>BL</given-names></name><name><surname>Debbink</surname><given-names>K</given-names></name><name><surname>Agnihothram</surname><given-names>S</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Scobey</surname><given-names>T</given-names></name><name><surname>Ge</surname><given-names>XY</given-names></name><name><surname>Donaldson</surname><given-names>EF</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><etal/></person-group><article-title>A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence</article-title><source>Nat Med</source><year>2015</year><volume>21</volume><fpage>1508</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC4797993</pub-id><pub-id pub-id-type="pmid">26552008</pub-id><pub-id pub-id-type="doi">10.1038/nm.3985</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noll</surname><given-names>KE</given-names></name><name><surname>Whitmore</surname><given-names>AC</given-names></name><name><surname>West</surname><given-names>A</given-names></name><name><surname>Mccarthy</surname><given-names>MK</given-names></name><name><surname>Morrison</surname><given-names>CR</given-names></name><name><surname>Plante</surname><given-names>KS</given-names></name><name><surname>Hampton</surname><given-names>BK</given-names></name><name><surname>Kollmus</surname><given-names>H</given-names></name><name><surname>Pilzner</surname><given-names>C</given-names></name><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross</article-title><source>Cell Rep</source><year>2020</year><volume>31</volume><elocation-id>107587</elocation-id><pub-id pub-id-type="pmcid">PMC7195006</pub-id><pub-id pub-id-type="pmid">32348764</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107587</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtsuka</surname><given-names>N</given-names></name><name><surname>Taguchi</surname><given-names>F</given-names></name></person-group><article-title>Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>8860</fpage><lpage>3</lpage><pub-id pub-id-type="pmcid">PMC192354</pub-id><pub-id pub-id-type="pmid">9343248</pub-id><pub-id pub-id-type="doi">10.1128/jvi.71.11.8860-8863.1997</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pairo-Castineira</surname><given-names>E</given-names></name><name><surname>Clohisey</surname><given-names>S</given-names></name><name><surname>Klaric</surname><given-names>L</given-names></name><name><surname>Bretherick</surname><given-names>AD</given-names></name><name><surname>Rawlik</surname><given-names>K</given-names></name><name><surname>Pasko</surname><given-names>D</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><name><surname>Parkinson</surname><given-names>N</given-names></name><name><surname>Fourman</surname><given-names>MH</given-names></name><name><surname>Russell</surname><given-names>CD</given-names></name><name><surname>Furniss</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genetic mechanisms of critical illness in COVID-19</article-title><source>Nature</source><year>2021</year><volume>591</volume><fpage>92</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">33307546</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>A</given-names></name><name><surname>Deming</surname><given-names>D</given-names></name><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Yount</surname><given-names>B</given-names></name><name><surname>Vogel</surname><given-names>L</given-names></name><name><surname>Herman</surname><given-names>BD</given-names></name><name><surname>Sheahan</surname><given-names>T</given-names></name><name><surname>Heise</surname><given-names>M</given-names></name><name><surname>Genrich</surname><given-names>GL</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name><etal/></person-group><article-title>A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>e5</fpage><pub-id pub-id-type="pmcid">PMC1769406</pub-id><pub-id pub-id-type="pmid">17222058</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030005</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>A</given-names></name><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Martinez</surname><given-names>DR</given-names></name><name><surname>Winkler</surname><given-names>ES</given-names></name><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Hawkins</surname><given-names>PE</given-names></name><name><surname>Gully</surname><given-names>KL</given-names></name><name><surname>Graham</surname><given-names>RL</given-names></name><name><surname>Scobey</surname><given-names>DT</given-names></name><name><surname>Bell</surname><given-names>TA</given-names></name><etal/></person-group><article-title>A Multitrait Locus Regulates Sarbecovirus Pathogenesis</article-title><source>mBio</source><year>2022</year><volume>13</volume><elocation-id>e0145422</elocation-id><pub-id pub-id-type="pmcid">PMC9426612</pub-id><pub-id pub-id-type="pmid">35862771</pub-id><pub-id pub-id-type="doi">10.1128/mbio.01454-22</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><collab>Severe Covid-19 GWAS Group</collab><article-title>Genomewide Association Study of Severe Covid-19 with Respiratory Failure</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>1522</fpage><lpage>1534</lpage><pub-id pub-id-type="pmcid">PMC7315890</pub-id><pub-id pub-id-type="pmid">32558485</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa2020283</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>JF</given-names></name><name><surname>Shastri</surname><given-names>AJ</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Weldon</surname><given-names>CH</given-names></name><name><surname>Filshtein-Sonmez</surname><given-names>T</given-names></name><name><surname>Coker</surname><given-names>D</given-names></name><name><surname>Symons</surname><given-names>A</given-names></name><name><surname>Esparza-Gordillo</surname><given-names>J</given-names></name><name><surname>Andme</surname><given-names>C-T</given-names></name><name><surname>Aslibekyan</surname><given-names>S</given-names></name><name><surname>Auton</surname><given-names>A</given-names></name></person-group><article-title>Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>801</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">33888907</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigmon</surname><given-names>JS</given-names></name><name><surname>Blanchard</surname><given-names>MW</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name><name><surname>Bell</surname><given-names>TA</given-names></name><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Brockmann</surname><given-names>GA</given-names></name><name><surname>Burks</surname><given-names>AW</given-names></name><name><surname>Calabrese</surname><given-names>JM</given-names></name><name><surname>Caron</surname><given-names>KM</given-names></name><name><surname>Cheney</surname><given-names>RE</given-names></name><name><surname>Ciavatta</surname><given-names>D</given-names></name><etal/></person-group><article-title>Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research</article-title><source>Genetics</source><year>2020</year><volume>216</volume><fpage>905</fpage><lpage>930</lpage><pub-id pub-id-type="pmcid">PMC7768238</pub-id><pub-id pub-id-type="pmid">33067325</pub-id><pub-id pub-id-type="doi">10.1534/genetics.120.303596</pub-id></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CM</given-names></name><name><surname>Proulx</surname><given-names>MK</given-names></name><name><surname>Olive</surname><given-names>AJ</given-names></name><name><surname>Laddy</surname><given-names>D</given-names></name><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Moss</surname><given-names>C</given-names></name><name><surname>Gutierrez</surname><given-names>NM</given-names></name><name><surname>Bellerose</surname><given-names>MM</given-names></name><name><surname>Barreira-Silva</surname><given-names>P</given-names></name><name><surname>Phuah</surname><given-names>JY</given-names></name><name><surname>Baker</surname><given-names>RE</given-names></name><etal/></person-group><article-title>Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype</article-title><source>mBio</source><year>2016</year><volume>7</volume><pub-id pub-id-type="pmcid">PMC5030360</pub-id><pub-id pub-id-type="pmid">27651361</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01516-16</pub-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thieulent</surname><given-names>CJ</given-names></name><name><surname>Dittmar</surname><given-names>W</given-names></name><name><surname>Balasuriya</surname><given-names>UBR</given-names></name><name><surname>Crossland</surname><given-names>NA</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Richt</surname><given-names>JA</given-names></name><name><surname>Carossino</surname><given-names>M</given-names></name></person-group><article-title>Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice</article-title><source>mSphere</source><year>2023</year><volume>8</volume><elocation-id>e0055822</elocation-id><pub-id pub-id-type="pmcid">PMC9942576</pub-id><pub-id pub-id-type="pmid">36728430</pub-id><pub-id pub-id-type="doi">10.1128/msphere.00558-22</pub-id></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Threadgill</surname><given-names>DW</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name><name><surname>De Villena</surname><given-names>FP</given-names></name></person-group><article-title>The collaborative cross: a recombinant inbred mouse population for the systems genetic era</article-title><source>ILAR J</source><year>2011</year><volume>52</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">21411855</pub-id></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>T</given-names></name><name><surname>Lamkin</surname><given-names>E</given-names></name><name><surname>Ikeh</surname><given-names>K</given-names></name><name><surname>March</surname><given-names>A</given-names></name><name><surname>Frere</surname><given-names>J</given-names></name><name><surname>Crompton</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>L</given-names></name><name><surname>Fanning</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>WY</given-names></name><name><surname>Muoio</surname><given-names>D</given-names></name><etal/></person-group><article-title>SARS-CoV-2 hijacks host cell genome instability pathways</article-title><source>Res Sq</source><year>2022</year></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>F</given-names></name><name><surname>Xiong</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Abnormal global alternative RNA splicing in COVID-19 patients</article-title><source>PLoS Genet</source><year>2022</year><volume>18</volume><elocation-id>e1010137</elocation-id><pub-id pub-id-type="pmcid">PMC9089920</pub-id><pub-id pub-id-type="pmid">35421082</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1010137</pub-id></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Qin</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>R</given-names></name><name><surname>Pei</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19</article-title><source>Front Immunol</source><year>2022</year><volume>13</volume><elocation-id>821664</elocation-id><pub-id pub-id-type="pmcid">PMC8858946</pub-id><pub-id pub-id-type="pmid">35197985</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.821664</pub-id></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Philippot</surname><given-names>Q</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>WT</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Stenson</surname><given-names>PD</given-names></name><name><surname>Palacin</surname><given-names>PS</given-names></name><name><surname>Colobran</surname><given-names>R</given-names></name><name><surname>Boisson</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genome-wide detection of human variants that disrupt intronic branchpoints</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><elocation-id>e2211194119</elocation-id><pub-id pub-id-type="pmcid">PMC9636908</pub-id><pub-id pub-id-type="pmid">36306325</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2211194119</pub-id></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>NS</given-names></name><name><surname>Zheng</surname><given-names>BJ</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name><name><surname>Poon</surname><given-names>XIE</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>PH</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Chang</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>JP</given-names></name><name><surname>Liu</surname><given-names>XQ</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People‚Äôs Republic of China, in February, 2003</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1353</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC7112415</pub-id><pub-id pub-id-type="pmid">14585636</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(03)14630-2</pub-id></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>R</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title><source>Lancet</source><year>2020a</year><volume>395</volume><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="pmcid">PMC7270627</pub-id><pub-id pub-id-type="pmid">32171076</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Wang</surname><given-names>XG</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Si</surname><given-names>HR</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>HD</given-names></name><etal/></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><year>2020b</year><volume>579</volume><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="pmcid">PMC7095418</pub-id><pub-id pub-id-type="pmid">32015507</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ning</surname><given-names>K</given-names></name><etal/></person-group><article-title>An epigenome-wide DNA methylation study of patients with COVID-19</article-title><source>Ann Hum Genet</source><year>2021</year><volume>85</volume><fpage>221</fpage><lpage>234</lpage><pub-id pub-id-type="pmcid">PMC8441705</pub-id><pub-id pub-id-type="pmid">34185889</pub-id><pub-id pub-id-type="doi">10.1111/ahg.12440</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>CC strains demonstrate variable response to SARS-CoV MA15 infection.</title><p>A) Weight loss for four dpi, B) lung congestion score, and C) log-transformed viral titer following infection with SARS-CoV MA15 in four female mice from each of 10 CC strains. D) Weight loss, E) lung congestion scores and F) log-transformed viral titer in four female mice from each of three CC strains, chosen for their divergent responses in the initial screen.</p></caption><graphic xlink:href="EMS189612-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Disease phenotypes after SARS-CoV MA15, SARS-CoV-2 MA10, and HKU3-CoV MA in CC006xCC044 F2 mice.</title><p>(A) Weight loss in n=391 F2 mice after infection with SARS-CoV MA15. (B) Weight loss in n=274 F2 mice after infection with SARS-CoV-2 MA10. (C) Weight loss in n=90 F2 mice after infection with HKU3-CoV MA. Red and blue lines in A-C represent average body weight trajectory of CC006 and CC044 mice, respectively, after infection with SARS-CoV MA15 (see <xref ref-type="fig" rid="F1">Fig. 1A</xref>). (D) Distribution of congestion scores in F2 mice, colored by infection group.</p></caption><graphic xlink:href="EMS189612-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Genome scans from QTL mapping on A) weight loss on day 3 and B) congestion score in SARS-CoV MA15-infected F2 mice, and C) weight loss on day 3 and D) congestion score in SARS-CoV-2 MA10-infected F2 mice. Solid and dashed lines represent 5% and 10% significance thresholds, respectively. <italic>HrS43</italic> overlaps with <italic>HrS26</italic> previously mapped for SARS-CoV MA15 in CC011xCC074 F2 cross.</p></caption><graphic xlink:href="EMS189612-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Relationship between genotype at <italic>HrS43</italic> peak marker S3N094839317 and weight loss (AAC) in A) SARS-CoV MA15-infected mice (genome-wide adjusted P = 1.6x10<sup>-3</sup>), B) SARS-CoV-2 MA10-infected mice (genome-wide adjusted P = 8.6x10<sup>-2</sup>), and C) HKU3-CoV MA-infected mice (P = 0.05).</p></caption><graphic xlink:href="EMS189612-f004"/></fig><fig id="F5" position="float"><graphic xlink:href="EMS189612-f005"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Quantitative trait loci identified in CC006xCC044 F2 mice. Next to genome-wide adjusted p-values, *** indicates highly significant (P &lt; 0.005), ** indicates significant (P &lt; 0.05) and * indicates suggestive (P &lt; 0.10).</p></caption><table frame="hsides" rules="rows"><tbody><tr><td valign="top" align="center" style="background-color:#dbdbdb"/><td valign="top" align="center" colspan="2" style="background-color:#dbdbdb">Associated phenotype(s)</td><td valign="top" align="center" style="background-color:#dbdbdb"/><td valign="top" align="center" rowspan="2" style="background-color:#dbdbdb">Genome-wide adjusted p-value</td><td valign="top" align="center" rowspan="2" style="background-color:#dbdbdb">Phenotypic variation explained (%)</td></tr><tr><td valign="top" align="center" style="background-color:#dbdbdb">QTL ID</td><td valign="top" align="center" style="background-color:#dbdbdb">Infection</td><td valign="top" align="center" style="background-color:#dbdbdb">Phenotype</td><td valign="top" align="center" style="background-color:#dbdbdb">Chromosome: position (CI) (Mb)</td></tr><tr><td valign="middle" align="left" rowspan="9"><italic>HrS43</italic></td><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 9: 120.98 (117.38-123.56)</td><td valign="top" align="left">0.00028 (***)</td><td valign="top" align="right">13.76%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (4 dpi)</td><td valign="top" align="left">Chr 9: 123.56 (117.38-123.56)</td><td valign="top" align="left">0.00079 (***)</td><td valign="top" align="right">9.13%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 9: 120.98 (113.39-123.56)</td><td valign="top" align="left">0.00156 (***)</td><td valign="top" align="right">7.46%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (2 dpi)</td><td valign="top" align="left">Chr 9: 99.89 (98.92-120.98)</td><td valign="top" align="left">0.03884 (**)</td><td valign="top" align="right">12.85%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Congestion score</td><td valign="top" align="left">Chr 9: 122.63 (107.98-123.56)</td><td valign="top" align="left">0.05685 (*)</td><td valign="top" align="right">4.89%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 9: 118.88 (107.98-122.63)</td><td valign="top" align="left">0.00051 (***)</td><td valign="top" align="right">16.73%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Congestion score</td><td valign="top" align="left">Chr 9: 123.56 (117.38-123.56)</td><td valign="top" align="left">0.00063 (***)</td><td valign="top" align="right">7.11%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 9: 120.98 (108.17-123.56)</td><td valign="top" align="left">0.0086 (**)</td><td valign="top" align="right">7.45%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (2 dpi)</td><td valign="top" align="left">Chr 9: 120.98 (107.98-122.63)</td><td valign="top" align="left">0.015 (**)</td><td valign="top" align="right">17.74%</td></tr><tr><td valign="middle" align="left" rowspan="5"><italic>HrS44</italic></td><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 7: 68.24 (51.71-84.03)</td><td valign="top" align="left">0.00019 (***)</td><td valign="top" align="right">3.77%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Congestion score</td><td valign="top" align="left">Chr 7: 56.03 (51.71-84.03)</td><td valign="top" align="left">0.001 (***)</td><td valign="top" align="right">5.51%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 7: 67.86 (41.95-121.91)</td><td valign="top" align="left">0.017 (**)</td><td valign="top" align="right">7.35%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (2 dpi)</td><td valign="top" align="left">Chr 7: 126.16 (51.71-131.68)</td><td valign="top" align="left">0.027 (**)</td><td valign="top" align="right">10.91%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (4 dpi)</td><td valign="top" align="left">Chr 7: 68.24 (51.71-81.92)</td><td valign="top" align="left">4.7e-05 (***)</td><td valign="top" align="right">5.22%</td></tr><tr><td valign="middle" align="left" rowspan="3"><italic>HrS45</italic></td><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 12: 29.10 (28.23-53.54)</td><td valign="top" align="left">0.0093 (**)</td><td valign="top" align="right">0.65%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (4 dpi)</td><td valign="top" align="left">Chr 12: 53.54 (28.23-73.38)</td><td valign="top" align="left">0.018 (**)</td><td valign="top" align="right">3.18%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 12: 28.58 (28.23-73.38)</td><td valign="top" align="left">0.063 (*)</td><td valign="top" align="right">6.24%</td></tr><tr><td valign="middle" align="left" rowspan="2"><italic>HrS46</italic></td><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 2: 34.53 (20.28-51.39)</td><td valign="top" align="left">0.04533 (**)</td><td valign="top" align="right">0.78%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (4 dpi)</td><td valign="top" align="left">Chr 2: 34.53 (26.59-57.78)</td><td valign="top" align="left">0.07249 (*)</td><td valign="top" align="right">0.07%</td></tr><tr><td valign="middle" align="left" rowspan="2"><italic>HrS47</italic></td><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 19: 6.68 (3.53-34.65)</td><td valign="top" align="left">0.02314 (**)</td><td valign="top" align="right">5.64%</td></tr><tr><td valign="top" align="left">SARS-CoV</td><td valign="top" align="left">Weight loss (4 dpi)</td><td valign="top" align="left">Chr 19: 34.65 (5.21-39.65)</td><td valign="top" align="left">0.03195 (**)</td><td valign="top" align="right">1.95%</td></tr><tr><td valign="middle" align="left" rowspan="2"><italic>HrS48</italic></td><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 15: 87.41 (73.77-92.18)</td><td valign="top" align="left">0.045 (**)</td><td valign="top" align="right">6.76%</td></tr><tr><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (3 dpi)</td><td valign="top" align="left">Chr 15: 87.41 (73.77-101.56)</td><td valign="top" align="left">0.095 (*)</td><td valign="top" align="right">22.23%</td></tr><tr><td valign="middle" align="left"><italic>HrS49</italic></td><td valign="top" align="left">SARS-CoV-2</td><td valign="top" align="left">Weight loss (AAC)</td><td valign="top" align="left">Chr 2: 163.22 (118.55-165.41)</td><td valign="top" align="left">0.086 (*)</td><td valign="top" align="right">5.96%</td></tr></tbody></table></table-wrap></floats-group></article>